accord
morpholog
structur
pathogen
gener
divid
four
main
categori
virus
bacteria
fungi
despit
divers
pathogen
one
similar
share
caus
infecti
diseas
pathogen
usual
invad
host
interact
host
cell
membran
briefli
review
interact
differ
pathogen
host
interfac
virus
small
infecti
agent
grow
cell
divis
instead
use
host
metabol
complet
selfrepl
virus
infect
type
life
form
earth
anim
plant
microorgan
mode
viral
infect
replic
differ
greatli
speci
attach
basic
stage
viral
capsid
protein
specif
bind
receptor
host
cellular
exampl
hiv
infect
human
leukocyt
specif
interact
surfac
protein
receptor
coreceptor
bacteria
one
kind
biolog
cell
compos
wide
rang
prokaryot
microorgan
relationship
bacteria
human
complex
sometim
bacteria
offer
us
help
hand
exampl
probiot
help
us
digest
case
bacteria
subvers
caus
infecti
diseas
like
methicillinresist
staphylococcu
aureu
mrsa
typic
pathogen
bacteria
express
andor
releas
larg
domain
molecul
target
host
membran
facilit
mani
individu
host
molecular
mechan
interact
bacteria
host
differ
across
differ
speci
exampl
mani
gramposit
pathogen
secret
poreform
toxin
form
pore
cell
membran
lead
cell
lysi
wherea
gramneg
pathogen
secret
endotoxin
activ
macrophag
produc
inflammatori
fungu
member
eukaryot
organ
includ
mushroom
microorgan
mold
yeast
accord
differ
structur
size
surfac
properti
abil
secret
pathogen
factor
fungi
attack
host
cell
differ
way
includ
membran
disrupt
mechan
forc
membran
remodel
fungal
addit
moy
et
al
discov
candida
albican
abl
produc
peptid
toxin
directli
damag
host
membran
activ
host
parasit
relationship
differ
speci
evolutionari
biolog
one
life
form
parasit
live
anoth
life
form
host
although
parasit
may
caus
host
harm
host
adapt
structur
live
parasit
exampl
complet
life
cycl
blood
circul
malaria
parasit
produc
merozoit
attach
enter
red
blood
cell
rbc
parasit
asexu
divid
form
mani
copi
parasit
copi
exit
infect
rbc
infect
liposom
artifici
vesicl
compos
one
hydrophob
phospholipid
bilay
use
extens
system
deliveri
therapeut
compound
liposom
imit
capabl
cell
membran
sever
way
wide
util
model
membran
studi
infect
mechan
mani
pathogen
biomembran
interfac
figur
research
interact
pathogen
liposom
trace
back
bangham
et
al
found
streptolysin
abl
regul
cation
permeabl
multilay
follow
earli
mechanist
studi
research
appli
liposom
pathogen
substrat
emerg
infecti
diseas
area
exampl
liposom
microarray
use
ultrasensit
detect
variou
type
pathogen
includ
virus
bacteria
cellmembran
mimic
consist
synthet
lipid
along
function
ligand
promot
format
complex
effect
improv
detect
sensit
variou
electrochem
immunolog
assay
anoth
exampl
util
interact
direct
inhibit
pathogen
infect
liposom
pathogen
trap
detain
cellmembranemimick
liposom
therebi
prevent
attack
cellular
viral
bacteri
infect
model
treatment
function
liposom
demonstr
improv
subject
surviv
well
reduc
overal
engin
liposom
also
use
secondari
therapeut
supplement
tradit
antiinfect
drug
system
administr
nanoscal
liposom
along
penicillin
effect
protect
anim
pneumonia
aureuscaus
moreov
research
also
exploit
interact
infectiontrigg
drug
releas
motiv
target
therapeut
drug
specif
site
poreform
toxin
abl
bore
hole
synthet
liposom
vehicl
result
select
releas
vancomycin
infect
surfac
engin
liposom
specif
molecul
may
promot
applic
synthet
liposom
infecti
diseas
mage
et
al
instanc
success
modifi
liposom
antivir
antibodi
effect
protect
coxsacki
viru
rapid
develop
biotechnolog
nanotechnolog
physic
chemic
properti
phospholipid
bilay
may
tune
fine
improv
efficaci
variou
antiinfect
applic
addit
liposom
reconstitut
lipoprotein
also
extens
employ
develop
antiinfect
decoy
lipoprotein
inher
present
human
bodi
disklik
patch
phospholipid
bound
apolipoprotein
use
construct
ingredi
protein
control
method
promis
control
function
lipoprotein
compon
molecular
level
open
door
lipidcompat
ingredi
incorpor
lipoprotein
nanostructur
proton
pump
signal
protein
membraneassoci
enzym
integr
reconstitut
engin
lipoprotein
demonstr
interact
frequent
pathogen
lead
effect
suppress
pathogen
infect
inhibit
ascrib
lipoprotein
microdomain
also
rich
pathogentoxin
receptor
sphingomyelin
furthermor
develop
antiinfect
nanostructur
clinic
use
bricarello
et
al
prepar
reconstitut
highdens
lipoprotein
rhdl
integr
gangliosid
improv
affin
certain
pathogen
molecul
figur
modifi
rhdl
effect
inhibit
cholera
toxin
attach
epitheli
cell
prevent
toxinassoci
neg
outcom
although
promis
work
along
line
allevi
toxic
nanostructur
improv
interact
necessari
success
translat
rhdl
antiinfect
candid
cellmembranederiv
nanoparticl
present
attract
platform
antiinfect
applic
pathogen
evolv
util
abund
molecul
cell
although
synthet
liposom
straightforwardli
function
specif
ligand
proven
difficult
replic
mimic
complic
protein
composit
function
natur
cell
membran
natur
cellmembranederiv
vesicl
possess
uniqu
advantag
maintain
natur
composit
function
sourc
cell
membran
therebi
enabl
platform
exhibit
properti
would
otherwis
hard
moreov
emerg
genet
edit
technolog
employ
amend
antigen
profil
natur
cellular
membran
fit
differ
develop
biomimet
antiinfect
nanodecoy
de
carvalho
et
al
demonstr
tcellderiv
exosom
could
effici
suppress
infect
exosom
exhibit
complet
membran
protein
composit
sourc
cell
ensur
attach
effect
therebi
prevent
bind
enter
healthi
cell
addit
exosom
releas
certain
host
cell
also
util
suppress
bacteri
parasit
invas
specif
host
cell
mani
exotoxin
secret
bacteria
fungi
known
uniqu
capabl
lyse
erythrocyt
rbc
rbcderiv
nanovesicl
wide
employ
model
examin
kinet
remov
intracellular
content
cellmembranederiv
nanovesicl
inherit
lipid
glycan
protein
sourc
cell
enabl
interact
occur
natur
manner
develop
biomimet
formul
trap
exotoxin
secret
bacteria
hu
et
al
demonstr
poli
lacticcoglycol
acid
plga
nanoparticl
camouflag
rbc
membran
abl
serv
toxin
nanospong
absorb
poreform
toxin
divert
away
intend
moreov
rao
et
al
show
mosquito
hostcellmembranewrap
nanodecoy
effect
trap
zika
viru
zikv
divert
away
healthi
cellular
target
figur
mous
model
research
team
demonstr
nanodecoy
success
mitig
zikvcaus
inflammatori
respons
fetal
microcephali
compar
cellmembranederiv
vesicl
cellmembraneco
nanostructur
prone
membran
fusion
therefor
transfer
detain
pathogen
host
addit
due
structur
lipid
membran
shell
stabil
nanoparticl
core
benefit
vivo
consid
cellmembranemimick
nanodecoy
abl
trap
pathogen
natur
manner
obtain
complex
appli
develop
typic
vaccin
prepar
reli
heat
chemic
treatment
destruct
protein
tertiari
structur
lead
antigen
alter
reduc
howev
inher
balanc
efficaci
safeti
present
great
limit
vaccin
develop
recent
effort
focus
weaken
pathogen
infect
maintain
origin
structur
thu
enhanc
efficaci
safeti
trap
detent
pathogensexotoxin
nanodecoy
offer
chanc
denud
pathogen
infecti
capabl
without
compromis
immunogen
demonstr
novel
concept
pathogentoxin
sequestr
cellmembranemimick
nanodecoy
vaccin
hu
et
al
show
spontan
interact
rbc
membraneco
nanodecoy
poreform
toxin
present
facil
approach
develop
safe
effect
nanoparticl
vehicl
endow
mani
properti
benefici
antigen
process
pathogenstoxin
display
immun
cell
nativ
manner
nanoparticl
small
size
long
circul
promot
antigen
present
nanoparticl
carrier
primarili
absorb
cell
endocytosi
therebi
promot
local
metabol
pathogensexotoxin
endolysosom
section
properti
togeth
contribut
improv
safeti
effici
nanoparticletrap
pathogenstoxin
convent
antiinfect
strategi
primarili
depend
structurecustom
platform
antibodi
antisera
although
effect
formul
often
requir
accur
identif
pathogen
speci
proven
impract
administ
time
amidst
increas
awar
emerg
viru
epidem
well
rise
threat
drugresist
bacteria
broadli
applic
platform
tremend
potenti
treatment
infecti
diseas
indepth
biolog
research
elucid
differ
mechan
pathogen
infect
involv
attach
cellular
membran
biointerfac
invad
host
cell
recent
nanotechnolog
develop
result
varieti
nanoscal
cellmembranemimick
formul
includ
liposom
reconstitut
lipoprotein
cellmembran
nanostructur
much
effort
direct
toward
explor
interact
biomimet
nanodecoy
pathogensexotoxin
research
demonstr
success
protect
major
pathogen
infect
nanoparticl
nanoformul
infus
vivo
allevi
diseas
burden
multipl
infecti
diseas
moreov
pathogentoxin
trap
detent
cellularmembranebas
nanostructur
wider
implic
develop
safe
effect
cellmembranemimick
nanodecoy
repres
promis
technolog
enorm
translat
realiz
potenti
explor
detail
studi
requir
scalabl
crucial
factor
requir
clinic
translat
nanostructur
previou
work
robust
prepar
liposom
lipoprotein
cellmembran
nanoparticl
indic
need
explor
largescal
product
biomimet
move
forward
affin
key
issu
need
consid
mani
pathogen
clear
infect
mechan
strategi
includ
bioconjug
chemistri
genet
edit
employ
enhanc
specif
protein
express
result
enhanc
platform
promis
properti
bioinspir
nanodecoy
highli
customiz
especi
cellmembraneco
nanoparticl
although
previou
design
employ
plga
nanoparticl
core
easi
imagin
cellmembraneco
platform
form
mani
type
nanoparticl
magnet
nanoparticl
addit
magnet
cellmembranewrap
magnet
particl
local
target
site
away
suscept
final
although
nanoparticletrap
pathogen
mani
advantag
tradit
vaccin
develop
nanocomplex
contain
nondenatur
pathogen
unavoid
increas
safeti
risk
indepth
studi
need
prior
success
clinic
translat
novel
nanotechnolog
